Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung

被引:36
作者
Saijo, T
Ishii, G
Nagai, K
Funai, K
Nitadori, J
Tsuta, K
Nara, M
Hishida, T
Ochiai, A
机构
[1] Natl Canc Ctr Hosp, Div Thorac Oncol, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr, Res Inst, Div Pathol, Chiba, Japan
关键词
squamous cell carcinoma; peripheral; central; tissue microarray; CK; 7; 19;
D O I
10.1016/j.lungcan.2005.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The central type and peripheral type squamous cell carcinoma (SCC) of the lung have different clinicopathological characteristics, but, little is known about their biological characteristics. We investigated differences between the properties and phenotypes of peripheral-type (P-type) and central-type (C-type) SCC by performing an immunohistochemical. analysis of each type by tissue microarray analysis with a large panel. of antibodies. To examine strictly, we selected 20 P-type SCCs that were pathological stage T1 and limited to more peripherally than the fifth bronchial bifurcation, and 21 C-type SCCs that were pathological stage T1 and limited to a lobar bronchus. The results of the clinicopathological study showed that the patients with P-type SCC were significantly older than the patients with C-type SCC and that squamous metaplasia was predominant in C-type SCC than in P-type SCC. The 36 antibodies revealed different expression patterns of cytokeratin 7 (CK 7) and cytokeratin 19 (CK 19) between C-type and P-type SCC. CK 7 expression was more predominant in P-type SCC than in C-type SCC, and CK 19 expression was more predominant in C-type SCC than in P-type SCC. These results suggest that C-type and P-type SCC have different clinicopathological and biological features. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 27 条
[1]  
BROERS JLV, 1988, CANCER RES, V48, P3221
[2]  
CARTER D, 1985, SEMIN DIAGN PATHOL, V2, P226
[3]  
COLBY TV, 1995, TUMORS LOWER RESP TR
[4]   Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung [J].
Funai, K ;
Yokose, T ;
Ishii, G ;
Araki, K ;
Yoshida, J ;
Nishimura, M ;
Nagai, K ;
Nishiwaki, Y ;
Ochiai, A .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (07) :978-984
[5]   Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors [J].
Hoos, A ;
Urist, MJ ;
Stojadinovic, A ;
Mastorides, S ;
Dudas, ME ;
Leung, DHY ;
Kuo, D ;
Brennan, MF ;
Lewis, JJ ;
Cordon-Cardo, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (04) :1245-1251
[6]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]
[7]   Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression [J].
Jourdan, F ;
Sebbagh, N ;
Comperat, E ;
Mourra, N ;
Flahault, A ;
Olschwang, S ;
Duval, A ;
Hamelin, R ;
Flejou, JF .
VIRCHOWS ARCHIV, 2003, 443 (02) :115-121
[8]   Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer [J].
Kristiansen, G ;
Petersen, YYS ;
Kaufmann, O ;
Schlüns, K ;
Dietel, M ;
Petersen, I .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (09) :1089-1095
[9]  
LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227
[10]  
MCDOWELL EM, 1978, J NATL CANCER I, V61, P539